CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $53.50 ($1,070,059)
- 4 Planned sale PRESIDENT AND CEO sold 20,000 shares at an average $53.29 ($1,065,743)
- 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $56.88 ($1,706,440)
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $62.45 ($1,249,096)
- 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $59.13 ($1,773,790)
- 4 Exercise or conversion SVP, CHIEF TECHNICAL OFFICER acquired 5,580 shares (option exercise)
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $61.40 ($1,228,020)
- 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $57.15 ($1,714,451)
- 4 Open-market sale Director sold 29,881 shares at an average $56.53 ($1,689,294)
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $55.00 ($1,100,023)
- 4 Planned sale SVP, CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $53.93 ($269,662)
- 4 Planned sale SVP, CHIEF FINANCIAL OFFICER sold 30,000 shares at an average $51.93 ($1,557,940)
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at $49.43 ($494,260)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 20,000 shares at an average $50.32 ($1,006,300)
- 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $45.27 ($905,480)
- 4 Grant or award Director acquired 6,501 shares (grant or award)
- 4 Grant or award Director acquired 6,501 shares (grant or award)
- 4 Grant or award Director acquired 6,501 shares (grant or award)
- 4 Grant or award Director acquired 6,501 shares (grant or award)
Page 6 of 39 · 774 filings